MedTrace Logo

PRP Prevents Recurrence of Intrauterine Adhesions

NCT03629132 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-08-14

No results posted yet for this study

Summary

Effect of platelet-rich plasma (PRP) on uterine scar fibrosis, endometrial receptivity and pregnancy outcome in patients with severe intrauterine adhesions

Conditions

  • Intrauterine Adhesion

Interventions

PROCEDURE

Platelet-rich plasma

Platelet-rich plasma intrauterine injection

PROCEDURE

gel

Self-crosslinking sodium hyaluronate gel intrauterine injection

Sponsors & Collaborators

  • Yanhong Deng

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2019-08-01
Completion
2019-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03629132 on ClinicalTrials.gov